KATALYST & Co

About KATALYST & Co

KATALYST & Co. is a healthcare transformation company that integrates strategic advisory, capital investment, and global operational services. It was publicly launched on October 28, 2025, by co-founder and CEO Kat Marie Alvarez, a recognized healthcare leader with extensive experience in executive roles at major payers and providers. The company launched with $10 million in initial funding to support its mission. Alvarez's background includes managing over 12 million health plan members and overseeing more than $5 billion in healthcare transactions.

The firm operates on a business model that combines consulting with direct co-investment, aiming to align its capital and expertise to foster growth and scale for its partners. It serves a diverse client base that includes payers, provider groups, technology innovators, and private equity investors. For payers and providers, KATALYST & Co. focuses on strengthening value-based care (VBC) models, a key strategic focus driven by the national push towards full VBC implementation by 2030. For technology companies, it provides commercialization support, and for investors, it offers industry analysis and operational expertise to ensure portfolio growth.

The company's services are delivered through two main divisions. 'Katalyst & Co.' offers strategic services like growth planning, investment advisory, AI-enabled business process outsourcing (BPO), and go-to-market strategies. The 'Katalyst Health' division focuses on clinical ventures, including the development of Medicare Advantage and value-based clinic models, MSO/ACO infrastructure, and ensuring regulatory compliance. This dual structure allows the firm to provide end-to-end support, from high-level strategy to hands-on operational execution.